Resources
Here you can find updates on the work of the World Hepatitis Alliance as well as patient resources.
News feed
Calling for greater commitment to the fight against hepatitis at the World Health Assembly
The 68th session of the World Health Assembly (WHA68) took place in Geneva from 18th-26th May. On 25th May, the World Hepatitis Alliance was invited...
Supporting the launch of guidelines and policies to address viral hepatitis
WHO Injection Safety policy Every year 1.7 million people are infected with hepatitis B through unsafe injection and 315,000 with hepatitis C. Yet up...
Working closely with WHO to develop a global strategy
WHO Strategic and Technical Advisory Committee for hepatitis (STAC-HEP) meeting, Geneva, Switzerland, 19 – 20 February As part of an expert advisory...
Highlighting the importance of patient advocacy at international conferences
24th Conference of the Asian Pacific Association for the Study of the Liver (APASL), Istanbul, Turkey, 12 – 15 March Patient led advocacy is vital in...
How does the Alliance really represent hepatitis patients?
The World Hepatitis Alliance prides itself as the true voice of hepatitis patients living all over the world. All our work is overseen by an...
What is the future for hepatitis treatments? And how we can fund hepatitis programmes?
Discussions around hepatitis are dominated by the pioneering new treatments rapidly transforming the landscape and the ensuing heated discussions...
WHA in official relations with WHO: What does this mean for you?
Fundamental to our ability to influence global hepatitis policy and bring about real change in the world of hepatitis is our relationship with the...
Need some inspiration for action? : Initiatives from WHA members
Together our voices are stronger and united we can tackle this global killer! The World Hepatitis Alliance is fortunate enough to be made up of...
How will 2015 be a defining year for the Alliance?
Viral hepatitis is a global killer with alarming mortality rates, yet an increased global commitment to tackling the disease and ground-breaking new...
Exploring new treatment developments and innovative ways to finance healthcare
New therapeutic developments are revolutionising the way hepatitis is treated. But with a global lack of funding, how can these pioneering new drugs...
Assisting WHO in the development of a global strategy
World Health Organization Member States have urged WHO to develop a comprehensive global strategy on hepatitis. To assist in the development of this...
World Hepatitis Alliance’s ever-growing membership base
Central to the success of the World Hepatitis Alliance are our member groups around the world. To stimulate political interest in and action on...
Joining expert committees to promote harm reduction
Harm reduction policies are proven to save lives. Globally, as many as 67% of People Who Inject Drugs (PWIDs) have hepatitis C and an additional 8.4...
Promoting screening among high risk communities with new multi-lingual tool
In Europe, migrant populations are disproportionally affected by hepatitis B and C. Crucial to reducing the burden is improving screening among these...
Supporting the development of national action plans in South America
Government commitment to comprehensive national action plans is key to addressing the burden of viral hepatitis. To support the development of...